×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BLFS – biolife solutions, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BLFS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/12
08:32 am
blfs
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations [Yahoo! Finance]
Medium
Report
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations [Yahoo! Finance]
1/12
08:03 am
blfs
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations
Medium
Report
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations
1/5
12:01 pm
blfs
BioLife Solutions (NASDAQ:BLFS) was given a new $34.00 price target on by analysts at Northland Securities.
Low
Report
BioLife Solutions (NASDAQ:BLFS) was given a new $34.00 price target on by analysts at Northland Securities.
12/29
10:17 am
blfs
BioLife Solutions (NASDAQ:BLFS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
BioLife Solutions (NASDAQ:BLFS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
12/29
08:02 am
blfs
BioLife Solutions (NASDAQ:BLFS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Low
Report
BioLife Solutions (NASDAQ:BLFS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
12/19
10:02 am
blfs
Is BioLife Solutions, Inc. (NASDAQ:BLFS) Trading At A 49% Discount? [Yahoo! Finance]
Low
Report
Is BioLife Solutions, Inc. (NASDAQ:BLFS) Trading At A 49% Discount? [Yahoo! Finance]
12/11
08:33 am
blfs
BioLife Solutions' CFO Sells 30,000 Shares [Yahoo! Finance]
Low
Report
BioLife Solutions' CFO Sells 30,000 Shares [Yahoo! Finance]
12/10
07:17 am
blfs
BioLife Solutions (NASDAQ:BLFS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
BioLife Solutions (NASDAQ:BLFS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
1/12
08:04 am
blfs
Form 8-K BIOLIFE SOLUTIONS INC For: Jan 12
Medium
Report
Form 8-K BIOLIFE SOLUTIONS INC For: Jan 12
1/9
05:03 pm
blfs
Form 8-K BIOLIFE SOLUTIONS INC For: Jan 08
Medium
Report
Form 8-K BIOLIFE SOLUTIONS INC For: Jan 08
1/8
05:04 pm
blfs
Form 4 BIOLIFE SOLUTIONS INC For: Jan 06 Filed by: Mathew Aby J.
Low
Report
Form 4 BIOLIFE SOLUTIONS INC For: Jan 06 Filed by: Mathew Aby J.
1/8
05:04 pm
blfs
Form 4 BIOLIFE SOLUTIONS INC For: Jan 06 Filed by: Berard Todd
Low
Report
Form 4 BIOLIFE SOLUTIONS INC For: Jan 06 Filed by: Berard Todd
1/8
05:04 pm
blfs
Form 4 BIOLIFE SOLUTIONS INC For: Jan 06 Filed by: Aebersold Sarah
Low
Report
Form 4 BIOLIFE SOLUTIONS INC For: Jan 06 Filed by: Aebersold Sarah
1/8
05:04 pm
blfs
Form 4 BIOLIFE SOLUTIONS INC For: Jan 06 Filed by: Wichterman Troy
Low
Report
Form 4 BIOLIFE SOLUTIONS INC For: Jan 06 Filed by: Wichterman Troy
1/8
05:04 pm
blfs
Form 4 BIOLIFE SOLUTIONS INC For: Jan 06 Filed by: Foster Karen A.
Low
Report
Form 4 BIOLIFE SOLUTIONS INC For: Jan 06 Filed by: Foster Karen A.
1/8
12:16 pm
blfs
Form SCHEDULE 13G/A BIOLIFE SOLUTIONS INC Filed by: T. Rowe Price Investment Management, Inc.
Low
Report
Form SCHEDULE 13G/A BIOLIFE SOLUTIONS INC Filed by: T. Rowe Price Investment Management, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Form 8-K BIOLIFE SOLUTIONS INC For: Mar 16
15.4%
7/8 BioLife Solutions to Acquire SAVSU Technologies 12.4%
3/18 BioLife Solutions, Inc. 2019 Q4 - Results - Earnings Call Presentation [Seeking Alpha] 10.1%
7/22 BioLife Solutions Inc (NASDAQ: BLFS) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 7.4%
3/12 Form 4 BIOLIFE SOLUTIONS INC For: Mar 10 Filed by: Rice Michael 6.2%
11/20 BioLife Solutions Inc (NASDAQ: BLFS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $22.00 price target on the stock. 6.0%
8/12 BioLife Solutions Inc (NASDAQ: BLFS) was given a new $24.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock. 5.8%
2/19 BioLife Solutions Inc (NASDAQ: BLFS) is now covered by analysts at Benchmark Co.. They set a "buy" rating on the stock. 5.0%
3/27 Form 4 BIOLIFE SOLUTIONS INC For: Mar 25 Filed by: Mathers James 4.9%
2/12 Form SC 13G/A BIOLIFE SOLUTIONS INC Filed by: SANDLER CAPITAL MANAGEMENT 4.8%
7/8 BioLife Solutions to Acquire SAVSU Technologies 12.4%
3/18 BioLife Solutions, Inc. 2019 Q4 - Results - Earnings Call Presentation [Seeking Alpha] 10.1%
7/22 BioLife Solutions Inc (NASDAQ: BLFS) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 7.4%
3/12 Form 4 BIOLIFE SOLUTIONS INC For: Mar 10 Filed by: Rice Michael 6.2%
11/20 BioLife Solutions Inc (NASDAQ: BLFS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $22.00 price target on the stock. 6.0%
8/12 BioLife Solutions Inc (NASDAQ: BLFS) was given a new $24.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock. 5.8%
2/19 BioLife Solutions Inc (NASDAQ: BLFS) is now covered by analysts at Benchmark Co.. They set a "buy" rating on the stock. 5.0%
3/27 Form 4 BIOLIFE SOLUTIONS INC For: Mar 25 Filed by: Mathers James 4.9%
2/12 Form SC 13G/A BIOLIFE SOLUTIONS INC Filed by: SANDLER CAPITAL MANAGEMENT 4.8%
TOP News Decliners
3/11
Q4/2019 12/31/2019 EPS 0.000 ZacksConsensus -0.020 ActVsEst 0.020 - Beat
-29.5%
11/12 Form 10-Q BIOLIFE SOLUTIONS INC For: Sep 30 -12.1%
9/24 BioLife Solutions Announces Cell and Gene Therapy Bioproduction Innovation Accelerator -11.3%
8/8 BioLife Solutions Announces Second Quarter 2019 Financial Results -10.5%
3/6 Form 4 BIOLIFE SOLUTIONS INC For: Mar 04 Filed by: DE GREEF RODERICK -9.9%
3/13 BioLife Solutions Inc (NASDAQ: BLFS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.75 price target on the stock. -7.4%
8/22 Form 4 BIOLIFE SOLUTIONS INC For: Aug 20 Filed by: Mathers James -6.9%
3/26 Form 4 BIOLIFE SOLUTIONS INC For: Mar 24 Filed by: Mathew Aby J. -6.1%
11/29 Form 4 BIOLIFE SOLUTIONS INC For: Nov 26 Filed by: Mathers James -5.9%
10/29 BioLife Solutions Inc (NASDAQ: BLFS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock. -5.3%
11/12 Form 10-Q BIOLIFE SOLUTIONS INC For: Sep 30 -12.1%
9/24 BioLife Solutions Announces Cell and Gene Therapy Bioproduction Innovation Accelerator -11.3%
8/8 BioLife Solutions Announces Second Quarter 2019 Financial Results -10.5%
3/6 Form 4 BIOLIFE SOLUTIONS INC For: Mar 04 Filed by: DE GREEF RODERICK -9.9%
3/13 BioLife Solutions Inc (NASDAQ: BLFS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.75 price target on the stock. -7.4%
8/22 Form 4 BIOLIFE SOLUTIONS INC For: Aug 20 Filed by: Mathers James -6.9%
3/26 Form 4 BIOLIFE SOLUTIONS INC For: Mar 24 Filed by: Mathew Aby J. -6.1%
11/29 Form 4 BIOLIFE SOLUTIONS INC For: Nov 26 Filed by: Mathers James -5.9%
10/29 BioLife Solutions Inc (NASDAQ: BLFS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock. -5.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: